Somatostatin inhibits growth hormone-releasing factor-stimulated adenylate cyclase activity in GH3 cells

This publication has 15 references indexed in Scilit:

• Human Pancreatic Tumor Growth Hormone-Releasing Factor Stimulates Anterior Pituitary Adenylate Cyclase Activity, Adenosine 3′,5′-Monophosphate Accumulation, and Growth Hormone Release in a Calmodulin-Dependent Manner*
  Endocrinology, 1984
• Presence of an Adenylate Cyclase Dually Regulated by Somatostatin and Human Pancreatic Growth Hormone (GH)-Releasing Factor in GH-Secreting Cells
  Endocrinology, 1984
• Human Pancreatic Tumor Growth Hormone (GH)-Releasing Factor and Cyclic Adenosine 3′,5′-Monophosphate Evoke GH Release from Anterior Pituitary Cells: The Effects of Pertussis Toxin, Cholera Toxin, Forskolin, and Cycloheximide^*
  Endocrinology, 1984
• PROLONGED SOMATOSTATIN PRETREATMENT DESENSITIZES SOMATOSTATIN'S INHIBITION OF RECEPTOR-MEDIATED RELEASE OF ADRENOCORTICOTROPIN HORMONE AND SENSITIZES ADENYLATE CYCLASE
  Endocrinology, 1983
• Adenylate cyclase inhibition and GTPase stimulation by somatostatin in S49 lymphoma cyc⁻ variants are prevented by islet‐activating protein
  FEBS Letters, 1983
• A nucleotide regulatory site for somatostatin inhibition of adenylate cyclase in S49 lymphoma cells
  Nature, 1983
• Somatostatin is a potent activator of phosphoprotein phosphatases in the digestisve tract
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1981
• Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release
  FEBS Letters, 1979
• Stimulation of prolactin release by vasoactive intestinal peptide (VIP)
  European Journal of Pharmacology, 1978
• Fluorometric assay of proteins in the nanogram range
  Archives of Biochemistry and Biophysics, 1973